199 related articles for article (PubMed ID: 38612943)
1. Boosting Clear Cell Renal Carcinoma-Specific Drug Discovery Using a Deep Learning Algorithm and Single-Cell Analysis.
Wang Y; Chen X; Tang N; Guo M; Ai D
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612943
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
3. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
5. Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma.
Liu F; Wang P; Sun W; Jiang Y; Gong Q
Front Immunol; 2022; 13():874056. PubMed ID: 35734169
[TBL] [Abstract][Full Text] [Related]
6. Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.
Zhang C; Li Y; Qian J; Zhu Z; Huang C; He Z; Zhou L; Gong Y
Front Immunol; 2022; 13():1020729. PubMed ID: 36479115
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma.
Xiang J; Liu W; Liu S; Wang T; Tang H; Yang J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16015-16030. PubMed ID: 37689589
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
[TBL] [Abstract][Full Text] [Related]
9. Analysis of lncRNAs profiles associated with ferroptosis can predict prognosis and immune landscape and drug sensitivity in patients with clear cell renal cell carcinoma.
Zong H; Li A; Huang Y; Che X; Zhang Y; Ma G; Zhou Z
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23464. PubMed ID: 37477388
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
11. Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.
Gong Q; Jiang Y; Xiong J; Liu F; Guan J
Front Immunol; 2023; 14():1199002. PubMed ID: 37503331
[TBL] [Abstract][Full Text] [Related]
12. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
Front Immunol; 2022; 13():934243. PubMed ID: 36189255
[TBL] [Abstract][Full Text] [Related]
14. Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8
Lu T; Zhang J; Lu S; Yang F; Gan L; Wu X; Song H; Liu S; Xu C; Han D; Yang B; Wen W; Qin W; Yang L
Cancer Immunol Immunother; 2023 Jun; 72(6):1739-1750. PubMed ID: 36646951
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Profiling Reveals Kidney Neutrophil Heterogeneity in Both Healthy People and ccRCC Patients.
Meng Y; Cai K; Zhao J; Huang K; Ma X; Song J; Liu Y
J Immunol Res; 2021; 2021():5598627. PubMed ID: 33791390
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced computed tomography images.
Yang Y; Huang H; Liang H
J Gene Med; 2023 Jul; 25(7):e3494. PubMed ID: 36869574
[TBL] [Abstract][Full Text] [Related]
18. Single-cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment.
Guan B; Li M; Cui D; Shen C; Hao Z; Li X
J Cell Mol Med; 2024 Mar; 28(6):e18186. PubMed ID: 38445803
[TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptome analysis revealing the intratumoral heterogeneity of ccRCC and validation of MT2A in pathogenesis.
Wang J; Zuo Z; Yu Z; Chen Z; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Ye F; Ma B; Sun Z
Funct Integr Genomics; 2023 Sep; 23(4):300. PubMed ID: 37713131
[TBL] [Abstract][Full Text] [Related]
20. The single-cell evolution trajectory presented different hypoxia heterogeneity to reveal the carcinogenesis of genes in clear cell renal cell carcinoma: Based on multiple omics and real experimental verification.
Ma B; Qin L; Sun Z; Wang J; Tran LJ; Zhang J; Ye F; Liu Y; Chen M
Environ Toxicol; 2024 Feb; 39(2):869-881. PubMed ID: 37886854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
